Uncategorised - European Medical Journal

ADVENT Dermatology

ADVENT is a medical education non-promotional program for healthcare professionals organized by Sanofi and Regeneron…

Review of IDWeek 2023

This year’s IDWeek, the joint annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology…

Interview: Shweta Anjan

TID is an exciting and rapidly expanding field. I began my career as a medical student at Kasturba Medical College in Manipal, India…

Review of the European Academy of Dermatology and Venereology (EADV) Congress 2023

BERLIN, Germany, was the setting for the 2023 European Academy of Dermatology and Venereology (EADV) Congress. With over 15,500 attendees…

Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas

Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…

Efficacy and Improvement of Qualify of Life in Patients Treated with Brodalumab in Real Clinical Practice: A Case Series of 31 Patients

Brodalumab, a fully human recombinant monoclonal antibody of the IgG2 type, binds strongly to IL-17 receptor A,3 effectively inhibiting…

Atopic Dermatitis

Eyerich began his presentation by explaining that although the four primary factors in the pathogenesis of atopic dermatitis…

Clinical Presentation and Diagnostic Features of Onychomatricoma: A Case Report

Onychomatricoma is an infrequent, benign fibroepithelial tumour originating from the nail matrix. While the exact cause of onychomatricoma…

Under the Microscope: Artificial Intelligence in Healthcare

AI in healthcare is emerging and continually evolving, with seemingly infinite potential, including improving screening and diagnosis…

Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity

Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…